Detalhe da pesquisa
1.
Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets.
Blood
; 125(26): 4042-51, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25869284
2.
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.
Blood
; 126(6): 779-89, 2015 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26002965
3.
Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases.
ACS Med Chem Lett
; 3(12): 997-1002, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900421
4.
Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic index.
J Med Chem
; 55(7): 3250-60, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22380736